Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $616.0000 (-1.09%) ($616.0000 - $616.0000) on Tue. Nov. 9, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.93% (three month average) | RSI | 71 | Latest Price | $616.0000(-1.09%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.7% a day on average for past five trading days. | Weekly Trend | REGN advances 4.3% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(53%) XLV(40%) DIA(39%) IWD(38%) SPY(37%) | Factors Impacting REGN price | REGN will decline at least -0.965% in a week (0% probabilities). VIXM(-21%) UUP(-7%) TBT(-7%) VXX(-5%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.965% (StdDev 1.93%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $629.68(-2.17%) | 10 Day Moving Average | $627.83(-1.88%) | 20 Day Moving Average | $597.18(3.15%) | To recent high | -10% | To recent low | 13.5% | Market Cap | $65.314b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |